Clinical Trial Update: Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating the long-term safety, tolerability, and efficacy of ponesimod in relapsing-remitting multiple sclerosis has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Ponesimod (ponesimod)

Snippet

Sponsor: Actelion | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2024-10-01